Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Colistin for Ventilator-associated Tracheobronchitis
NCT02619786Phase 3Unknown
- Sponsor
- Mahidol University
- Start
- Dec 2015
- Primary completion
- May 2017
- Modality
- Peptides
01
Overview
Phase 3, open-label, single-arm trial of colistin in ventilator-associated tracheobronchitis (VAT), sponsored by Mahidol University. Primary endpoint: Number of Patients With Cure, Improved, Failure or Death at 2 weeks. Status: unknown.
02
Drugs
colistin
03
Conditions
ventilator-associated tracheobronchitis (VAT)
Beyond the preview
Go deeper on NCT02619786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02619786.